These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10207352)

  • 1. Immune globulin intravenous products--notice to hospitals.
    Hogan V
    CMAJ; 1999 Apr; 160(7):1051-2, 1055-6. PubMed ID: 10207352
    [No Abstract]   [Full Text] [Related]  

  • 2. Important drug warning: Immune Globulin Intravenous (human) (IGIV) products.
    Epstein JS; Zoon KC
    Neonatal Netw; 2000 Mar; 19(2):60-2. PubMed ID: 11949001
    [No Abstract]   [Full Text] [Related]  

  • 3. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Rh(o) [D] immune globulin [human] (WinRho SDF): suspected hemolytic/renal adverse reactions.
    Parker C
    CMAJ; 2000 Oct; 163(7):881, 885. PubMed ID: 11033724
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
    Macdonald L
    CMAJ; 2000 Oct; 163(7):879-81, 883-5. PubMed ID: 11033723
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure induced by intravenous immune globulin.
    Arunabh ; Arunabh S; Kumar G; Avila V
    Am Fam Physician; 1996 Feb; 53(3):862, 865. PubMed ID: 8594861
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.
    Szarfman A; Doraiswamy PM; Tonning JM; Levine JG
    Arch Neurol; 2006 Feb; 63(2):299-300; author reply 300. PubMed ID: 16476828
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal insufficiency and failure associated with immune globulin intravenous therapy--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):518-21. PubMed ID: 10401909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of immune globulin intravenous for treatment of immune deficient patients--United States, 1997-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Mar; 48(8):159-62. PubMed ID: 10079062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A challenge to the data miners.
    Lilienfeld DE;
    Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):881-4. PubMed ID: 15558812
    [No Abstract]   [Full Text] [Related]  

  • 16. A decade of WHO Information Exchange System 'ALERT'.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Aug; 18(3):117-9. PubMed ID: 10592833
    [No Abstract]   [Full Text] [Related]  

  • 17. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous administration of immunoglobulin--preparations and theoretical basis of their use].
    Jankowski A
    Postepy Hig Med Dosw; 2002; 56 Suppl():5-12. PubMed ID: 12661409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.